XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

ORDINARY SHARES PURCHASE WARRANTS ISSUED TO INVESTORS | 6 Months Ended
--- | ---
Dec. 31, 2024
ORDINARY SHARES PURCHASE WARRANTS ISSUED TO INVESTORS |
ORDINARY SHARES PURCHASE WARRANTS ISSUED TO INVESTORS | NOTE 17. ORDINARY SHARES PURCHASE WARRANTS ISSUED TO INVESTORS In June 2021, the Company issued to some institutional investors warrants to purchase an aggregate of up to 8,814,102 (489,673 shares post 2024 Reverse Split) Class A Ordinary Shares. (the “Warrant 2021”) The warrants are subject to deemed-liquidation redemption features and are therefore classified as a liability in accordance with FASB ASC 480. Warrant liability is classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. The warrant liability is re-valued at each reporting period with the change in fair value recorded through earnings. The Company established the initial fair value of the warrants at $34,860,000. During the year ended June 30, 2023, the exercise price of warrants to purchase an aggregate of up to 7,950,769 (441,710 shares post 2024 Reverse Split) Class A Ordinary Shares was adjusted to $0.80 ($14.40 post 2024 Reverse Split), and the exercise price of the remaining warrants to purchase an aggregate of up to 863,333 (47,963 shares post 2024 Reverse Split) Class A Ordinary Shares remained at $6.24 ($112.32 post 2024 Reverse Split). On December 14, 2023, the Company entered into a Warrant Purchase Agreement with certain accredited investors pursuant to which the Company agreed to buy back an aggregate of 7,950,769 (441,710 warrants post 2024 Reverse Split) warrants from the investors, and the investors agreed to sell the Warrants back to the Company. The purchase price for each Warrant was $0.25 ($4.50 post 2024 Reverse Split). As of December 31, 2024, The Company still holds the investor 863,333 (47,963 warrants post 2024 Reverse Split) warrants. As of June 30, 2024 and December 31, 2024, the fair value of the warrant liability of the Warrant 2021 was $959 and $2,398 (¥17,504). During the six months ended December 31, 2023 and 2024, there was change in fair value of warrant liability in an aggregate amount of $197,692 and $1,415, respectively. ​ The key inputs into the Black-Scholes model were as follows at their measurement dates: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, | ​ | June 30, |
Input |  | 2024 |  | 2024 | ​
Number of warrants | ​ | $ | 47,963 | ​ | $ | 47,963 | ​
Share price | ​ | $ | 2.09 | ​ | $ | 0.02 | ​
Risk-free interest rate | ​ |  | 4.25 | % |  | 4.62 | %
Volatility | ​ |  | 115 | % |  | 105 | %
Exercise price | ​ | $ | 112.32 | ​ | $ | 112.32 | ​
Warrant life | ​ |  | 1.96 years | ​ |  | 2.46 years | ​
​ The following table presents information about the Company’s warrants that were measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2024, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Quoted Prices In |  | Significant Other |  | Significant Other
​ | ​ | June 30, | ​ | Active Markets | ​ | Observable Inputs | ​ | Unobservable Inputs
Description | ​ | 2024 | ​ | (Level 1) | ​ | (Level 2) | ​ | (Level 3)
Liabilities: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Warrant liability - non-current | ​ | $ | 959 | ​ | $ | — | ​ | $ | — | ​ | $ | 959
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Quoted Prices In |  | Significant Other |  | Significant Other
​ | ​ | December 31, | ​ | Active Markets | ​ | Observable Inputs | ​ | Unobservable Inputs
Description |  | 2024 |  | (Level 1) | ​ | (Level 2) | ​ | (Level 3)
Liabilities: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Warrant liability - non-current | ​ | $ | 2,398 | ​ | $ | — | ​ | $ | — | ​ | $ | 2,398
​ The following table summarizes the Company’s Warrants activities and status of Warrants as of December 31, 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted |  | Average
​ | ​ | ​ | ​ | Average | ​ | Remaining
​ | ​ | ​ | ​ | Exercise Price | ​ | Period
Warrants | ​ | Warrants* | ​ | Per Share* | ​ | (Years)
Outstanding as of June 30, 2023 |  | 1,045,367 | ​ | $ | 18.90 |  | 4.40
Issued |  | — | ​ |  | — |  | —
Redeemed |  | (997,404) | ​ |  | 14.40 |  | —
Forfeited | ​ | — | ​ | ​ | — | ​ | —
Exercised |  | — | ​ |  | — |  | —
Expired |  | — | ​ |  | — |  | —
Outstanding as of June 30, 2024 |  | 47,963 | ​ | $ | 112.32 |  | 2.96
Issued |  | — | ​ |  | — |  | —
Redeemed | ​ | — | ​ | ​ | — | ​ | —
Forfeited |  | — | ​ |  | — |  | —
Exercised |  | — | ​ |  | — |  | —
Expired |  | — | ​ |  | — |  | —
Outstanding as of December 31, 2024 |  | 47,963 | ​ | $ | 112.32 |  | 1.96
* Retrospectively restated for the 1-for-18 reverse share split on May 1, 2024.

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_WarrantsAndRightsNoteDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration